Low urinary 5-hydroxyindole acetic acid in fibromyalgia syndrome: Evidence in support of a serotonin-deficiency pathogenesis

Lyon Mediterranee Medical Medecine du Sud-Est

Volumn 34, Issue 3-4, 1998, Pages 14-21

  Kang, Y K ^a   Russell, I J ^a   Vipraio, G A ^a   Acworth, I N ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

5 Hydroxyindole acetic acid; Fibromyalgia; Pathogenesis; Serotonin; Substance P

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; SEDATIVE AGENT; SEROTONIN; SUBSTANCE P; TRYPTOPHAN;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL RESEARCH; CONTROLLED STUDY; EXCRETION; FEMALE; FIBROMYALGIA; HUMAN; MALE; NEUROCHEMISTRY; PAIN ASSESSMENT; PATHOGENESIS; TURNOVER TIME; URINE LEVEL;

EID: 0032452221     PISSN: 0399032X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)